Literature DB >> 16474410

Allogeneic stem cell transplantation after reduced-intensity conditioning in a patient with T-cell prolymphocytic leukemia: graft-versus-tumor effect and long-term remission.

H de Lavallade, C Faucher, S Fürst, J El-Cheikh, N Vey, D Coso, R Bouabdallah, A-M Stoppa, J-A Gastaut, D Blaise, M Mohty.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16474410     DOI： 10.1038/sj.bmt.1705294

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  6 in total

Review 1.  Prolymphocytic Leukemia: New Insights in Diagnosis and in Treatment.

Authors:  Aude Collignon; Anne Wanquet; Elsa Maitre; Edouard Cornet; Xavier Troussard; Thérèse Aurran-Schleinitz
Journal:  Curr Oncol Rep       Date:  2017-04       Impact factor: 5.075

2.  GvL effects in T-prolymphocytic leukemia: evidence from MRD kinetics and TCR repertoire analyses.

Authors:  L Sellner; M Brüggemann; M Schlitt; H Knecht; D Herrmann; T Reigl; A Krejci; V Bystry; N Darzentas; M Rieger; S Dietrich; T Luft; A D Ho; M Kneba; P Dreger
Journal:  Bone Marrow Transplant       Date:  2016-12-12       Impact factor: 5.483

Review 3.  Advances in the understanding and management of T-cell prolymphocytic leukemia.

Authors:  Kamel Laribi; Pierre Lemaire; Jeremy Sandrini; Alix Baugier de Materre
Journal:  Oncotarget       Date:  2017-11-01

4.  Risk Factors for Graft-Versus-Host Disease After Transplantation of Hematopoietic Stem Cells from Unrelated Donors in the China Marrow Donor Program.

Authors:  Fan Yang; Daopei Lu; Yu Hu; Xiaojun Huang; He Huang; Jing Chen; Depei Wu; Jianmin Wang; Chun Wang; Mingzhe Han; Hu Chen
Journal:  Ann Transplant       Date:  2017-06-27       Impact factor: 1.530

Review 5.  Advances in Cellular Therapy for T-Cell Prolymphocytic Leukemia.

Authors:  Indumathy Varadarajan; Karen Ballen
Journal:  Front Oncol       Date:  2022-02-11       Impact factor: 6.244

6.  Characteristics, outcomes, prognostic factors and treatment of patients with T-cell prolymphocytic leukemia (T-PLL).

Authors:  P Jain; E Aoki; M Keating; W G Wierda; S O'Brien; G N Gonzalez; A Ferrajoli; N Jain; P A Thompson; E Jabbour; R Kanagal-Shamanna; S Pierce; A Alousi; C Hosing; I Khouri; Z Estrov; J Cortes; H Kantarjian; F Ravandi; T M Kadia
Journal:  Ann Oncol       Date:  2017-07-01       Impact factor: 32.976
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.